EX
Expedia
EXPE13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 2 funds we track own this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying EXPE
Top funds mostly added to Expedia in Q2 (Apr–Jun)
Buying:
Funds2InsidersCongress
- Top funds2 of 2 bought more, 1 sold some. Largest: Patient Capital Management, $42.9M (1% of its portfolio).
- InsidersNo buys, 12 sales in 12 months.
- CongressNo trades disclosed in the last 12 months.
2 funds$43.2M held0.7% avg. weightQ2: 2 bought / 1 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026
Insider trades (Form 4)
Last 2 years · 26 filings